Your browser doesn't support javascript.
loading
Glucagon-like peptide-1 receptor agonist exenatide has no acute effect on MRI-measured exocrine pancreatic function in patients with type 2 diabetes: a randomized trial.
Smits, M M; Tonneijck, L; Muskiet, M H A; Kramer, M H H; Diamant, M; Pieters-van den Bos, I C; van Raalte, D H; Cahen, D L.
Afiliação
  • Smits MM; Diabetes Centre, Department of Internal Medicine, VU University Medical Centre, Amsterdam, The Netherlands.
  • Tonneijck L; Diabetes Centre, Department of Internal Medicine, VU University Medical Centre, Amsterdam, The Netherlands.
  • Muskiet MH; Diabetes Centre, Department of Internal Medicine, VU University Medical Centre, Amsterdam, The Netherlands.
  • Kramer MH; Diabetes Centre, Department of Internal Medicine, VU University Medical Centre, Amsterdam, The Netherlands.
  • Diamant M; Diabetes Centre, Department of Internal Medicine, VU University Medical Centre, Amsterdam, The Netherlands.
  • Pieters-van den Bos IC; Department of Radiology and Nuclear Medicine, VU University Medical Centre, Amsterdam, The Netherlands.
  • van Raalte DH; Diabetes Centre, Department of Internal Medicine, VU University Medical Centre, Amsterdam, The Netherlands.
  • Cahen DL; Department of Gastroenterology and Hepatology, Erasmus University Medical Centre, Rotterdam, The Netherlands.
Diabetes Obes Metab ; 18(3): 281-8, 2016 Mar.
Article em En | MEDLINE | ID: mdl-26640129

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peptídeos / Peçonhas / Pâncreas Exócrino / Diabetes Mellitus Tipo 2 / Receptor do Peptídeo Semelhante ao Glucagon 1 / Hipoglicemiantes Tipo de estudo: Clinical_trials Limite: Adult / Aged / Humans / Male / Middle aged Idioma: En Revista: Diabetes Obes Metab Assunto da revista: ENDOCRINOLOGIA / METABOLISMO Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peptídeos / Peçonhas / Pâncreas Exócrino / Diabetes Mellitus Tipo 2 / Receptor do Peptídeo Semelhante ao Glucagon 1 / Hipoglicemiantes Tipo de estudo: Clinical_trials Limite: Adult / Aged / Humans / Male / Middle aged Idioma: En Revista: Diabetes Obes Metab Assunto da revista: ENDOCRINOLOGIA / METABOLISMO Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Holanda